- Investing Ideas
- U.K. Pharmaceuticals & Biotech Pure Equity Growth
U.K. Pharmaceuticals & Biotech Pure Equity Growth
Results
9
Companies that has zero debt on their balance sheet and is forecast to grow at an exponential rate in the future.
9 companies
Corcept Therapeutics
Market Cap: US$9.6b
A biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
0I3Q
US$89.90
7D
-1.3%
1Y
24.9%
Camurus
Market Cap: SEK 38.0b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMXS
SEK 615.75
7D
9.2%
1Y
-12.0%
Camurus
Market Cap: SEK 37.4b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
0RD1
SEK 625.41
7D
12.8%
1Y
-10.0%
BioArctic
Market Cap: SEK 26.8b
Develops biological drugs for patients with central nervous system disorders in Sweden.
BIOABS
SEK 328.70
7D
0%
1Y
n/a
BioArctic
Market Cap: SEK 26.6b
Develops biological drugs for patients with central nervous system disorders in Sweden.
0RV2
SEK 293.60
7D
-9.7%
1Y
51.3%
Bonesupport Holding
Market Cap: SEK 13.6b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
BONEXS
SEK 219.70
7D
-4.3%
1Y
-30.6%
Bonesupport Holding
Market Cap: SEK 13.6b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
0RQO
SEK 199.00
7D
-17.1%
1Y
-38.7%
Kuros Biosciences
Market Cap: CHF 820.0m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
0RHR
CHF 20.82
7D
-4.4%
1Y
-27.1%
Kuros Biosciences
Market Cap: CHF 820.0m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURNz
CHF 20.90
7D
-2.5%
1Y
-28.3%